Clinical Trial Update: A Study of Tirzepatide (LY3298176) Versus Insulin Lispro (U100) in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine (U100) With or Without Metformin [Phase 3]

View source ↗

Summary

Phase 3 study comparing tirzepatide to insulin lispro in Type 2 diabetes patients inadequately controlled on basal insulin, with or without metformin; trial com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tirzepatide (tirzepatide)
• insulin lispro (insulin lispro)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 3 | Status: COMPLETED | Results posted: 2023-11-02